Chemotherapy prior to interventional LMBC treatment (without hormones) | 92 % (n = 54) | |
 | median number of applied lines (range) | 2 (0 - 8) |
Local treatment of breast cancer metastases prior to interventional LMBC treatment, overall | 68 % (n = 40) | |
 | surgery (for metastasis)a | n = 19 |
 | radiotherapya | n = 20 |
Bisphophonates prior to interventional LMBC treatment | n = 24 | |
Concomitant or subsequent breast cancer therapy (after initiation of interventional LMBC treatment), overall | 86 % (n = 51) | |
 | chemotherapya | n = 40 |
 | hormonesa | n = 22 |
 | surgerya | n = 7 |
 | radiotherapya | n = 14 |
Total number of interventional procedures for LMBCa | n = 97 | |
 | interstitial brachytherapy (BT) | n = 68 |
 | radioembolization (RE) | n = 34 |
 | radiofrequency ablation (RFA) | n = 5 |
Number of interventional procedures per patient (1/2/3/4/5/6/7) (n) | (37/13/5/0/2/1/1) | |
First treatment per patient (BT/RE/RFA/combination) (n) | (29/22/3/5) | |
Treatment modalities per patient (first and all subsequent procedures) | ||
 | RE only | n = 17 |
 | BT only | n = 25 |
 | RFA only | n = 1 |
 | BT and RE | n = 12 |
 | BT and RFA | n = 3 |
 | RE and RFA | n = 1 |